CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.17
-0.27 (-3.63%)
At close: 4:00PM EDT

7.17 0.00 (0.00%)
After hours: 4:00PM EDT

Stock chart is not supported by your current browser
Previous Close7.44
Open7.51
Bid6.19 x 100
Ask13.99 x 3000
Day's Range7.13 - 7.54
52 Week Range5.52 - 10.80
Volume109,768
Avg. Volume180,049
Market Cap349.23M
Beta1.80
PE Ratio (TTM)-11.49
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to ChemoCentryx, Inc. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube15 days ago

    ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis ChemoCentryx, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 8.94 million, Net Earnings of USD -9.24 million. Change in operating cash flow of -121.02% compared to same period last year is about the same as change in earnings, likely no significant movement ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : October 3, 2017
    Capital Cube16 days ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : October 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • All You Need To Know About ChemoCentryx Inc’s (CCXI) Risks
    Simply Wall St.17 days ago

    All You Need To Know About ChemoCentryx Inc’s (CCXI) Risks

    If you are looking to invest in ChemoCentryx Inc’s (NASDAQ:CCXI), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More...

  • Is There Now An Opportunity In ChemoCentryx Inc (CCXI)?
    Simply Wall St.last month

    Is There Now An Opportunity In ChemoCentryx Inc (CCXI)?

    ChemoCentryx Inc (NASDAQ:CCXI), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a decent share price growth in the teens level on the NasdaqGS over the lastRead More...

  • Capital Cube2 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : August 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CCXI earnings conference call or presentation 8-Aug-17 9:00pm GMT

    Q2 2017 ChemoCentryx Inc Earnings Call

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : August 10, 2017
    Capital Cube2 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : August 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press2 months ago

    ChemoCentryx reports 2Q loss

    The Mountain View, California-based company said it had a loss of 19 cents per share. The biopharmaceutical company posted revenue of $8.9 million in the period. ChemoCentryx shares have climbed 37 percent ...

  • New Strong Buy Stocks for July 18th
    Zacks3 months ago

    New Strong Buy Stocks for July 18th

    New Strong Buy Stocks for July 18th

  • ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%
    Zacks3 months ago

    ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%

    ChemoCentryx, Inc. (CCXI) moved big last session, as its shares rose over 6% on the day.

  • Capital Cube4 months ago

    ETFs with exposure to ChemoCentryx, Inc. : June 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ChemoCentryx, Inc. Here are 5 ETFs with the largest exposure to CCXI-US. Comparing the performance and risk of ChemoCentryx, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : June 8, 2017
    Capital Cube4 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : June 8, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CCXI earnings conference call or presentation 10-May-17 9:00pm GMT

    Q1 2017 ChemoCentryx Inc Earnings Call

  • Capital Cube5 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : May 15, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 21. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Pfizer Inc. and ... Read more (Read more...)

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : May 12, 2017
    Capital Cube5 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : May 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Associated Press5 months ago

    ChemoCentryx reports 1Q loss

    On a per-share basis, the Mountain View, California-based company said it had a loss of 12 cents. The biopharmaceutical company posted revenue of $8.2 million in the period. ChemoCentryx shares have dropped ...

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : April 6, 2017
    Capital Cube6 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : April 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Zacks7 months ago

    ChemoCentryx (CCXI) Shares March Higher, Can It Continue?

    ChemoCentryx, Inc. (CCXI) has been on the move lately as the stock has risen by 11.9% in the past four weeks, and it is currently trading well above its 20-Day SMA

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of CCXI earnings conference call or presentation 14-Mar-17 9:00pm GMT

    Q4 2016 ChemoCentryx Inc Earnings Call

  • Associated Press7 months ago

    ChemoCentryx reports 4Q loss

    The Mountain View, California-based company said it had a loss of 16 cents per share. The biopharmaceutical company posted revenue of $4.9 million in the period. For the year, the company reported that ...

  • TheStreet.com7 months ago

    Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

    ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.

  • Sio Capital Remains Bullish On These Stocks Despite Weak Performance
    Insider Monkey8 months ago

    Sio Capital Remains Bullish On These Stocks Despite Weak Performance

    As a healthcare-focused fund, Michael Castor‘s Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered by the S&P 500 and the 8.3% drop of the MSCI World Healthcare Index. In its annual letter, the investor said that two main factors for the weak performance were speculative investments, and […]

  • ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : January 19, 2017
    Capital Cube9 months ago

    ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ChemoCentryx, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : January 3, 2017
    Capital Cube9 months ago

    ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : January 3, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives ChemoCentryx, Inc. a score of 25. Our analysis is based on comparing ChemoCentryx, Inc. with the following peers – Fortress Biotech, Inc., Biogen Inc., Johnson & Johnson, AbbVie, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc Sponsored ADR, Teva Pharmaceutical Industries Limited Sponsored ADR, Amgen Inc., Pfizer Inc. and ... Read more (Read more...)